| A study of Metformin with / without Administration of Thymoquinone in Patients with Diabetes | A, Randomized, Open label, Prospective, Three Arm, Parallel, Multicenter study to Evaluate Efficacy and Safety of Metformin with / without Concomitant Administration of Thymoquinone in Patients with Type 2 Diabetes Mellitus. | CTRI/2018/11/016334 |
| Evaluation of Efficacy and Safety of Thymoquinone compared to Best supportive care in Patients with COVID-19 | Evaluation of Efficacy and Safety of Thymoquinone compared to Best supportive care in Patients with COVID-19. | CTRI/2020/05/025167 |
| A study of Thymoquinone tablets | An Open Label, Balanced, Randomized, Three-Treatment, Single-Period, Single Oral Dose, Parallel, Exploratory Pharmacokinetic Study Of Thymoquinone Tablet 12.5 mg, 25 mg, 50 mg In Normal, Healthy, Adult, Human Subjects Under Fasting Condition | CTRI/2020/12/029514 |
| Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin | Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin | NCT04852510 |
| The effect of thymoquinone on infantile spasm | Evaluation of the effect of thymoquinone in the treatment of infants with infantile refractory spasm | IRCT20200131046317N2 |
| Black seed as an oral cleansing agent | Evaluation of the clinical efficacy of Thymoquinone gel as an Anti plaque and Anti gingivitis agent: A blinded randomized study. | CTRI/2021/04/033045 |
| A study of Thymoquinone Gel 0.1% in Attenuating Oral Mucositis in Patients with Head and Neck Cancer ReceivingRadiotherapy with Chemotherapy. | A Prospective, Randomized, Placebo-Controlled, Two Arm, Multicenter Study to Evaluate Efficacy and Safety of Thymoquinone Gel 0.1% inAttenuating Oral Mucositis in Patients with Head and Neck Cancer Receiving Radiotherapy with Chemotherapy. | CTRI/2021/12/038575 |
| A study of nutraceutical product in Patients | A Randomized, Open label, Prospective, Three Arm, Parallel, Multicenter study to Evaluate Efficacy and Safety of Metformin with / without Concomitant Administration of Thymoquinone in Patients with Type 2 Diabetes Mellitus | CTRI/2021/08/036060 |
| Topical Thymoquinone in Psoriasis Vulgaris | Efficacy and Safety of Thymoquinone Ointment as a Potential New Therapeutic Modality of Psoriasis Vulgaris. | NCT06508372 |
| Comparative BE Study of BioSNEDS in healthy subjects | AN OPEN LABEL,BALANCED, SINGLE-DOSE,MULTI-TREATMENT, TWO PERIOD,TWO-WAY CROSSOVER, COMPARATIVE ORAL BIOAVAILABILITY STUDY OF THYMOPRO 50 MG BIOSNEDS (0.001004 G THYMOQUINONE/ML), BERBERISOL 500 MG BIOSNEDS (0.010046 G BERBERINE HCL/ML),RESVERASOL 1000 MG BIOSNEDS (0.020048 G RESVERATROL/ML),BIOQUERCETIN 475 MG BIOSNEDS (0.010045 G QUERCETIN/ML) ANDBIOBUTYRIN 500 MG BIOSNEDS (0.010096 G TRIBUTYRIN/ML) MANUFACTURED BY VERDANT NATURE SP Z.O.O., WITH CONVENTIONAL RESVERATROL EXTRACT 1000 MG (2 X 500 MG CAPSULE) DISTRIBUTED BY BIOLAB, CONVENTIONAL QUERCETIN 475 MG CAPSULE DISTRIBUTED BY SWANSON HEALTH PRODUCTS, CONVENTIONAL TRIBUTYRIN 500 MG CAPSULE DISTRIBUTED BY DEVA NUTRITION, CONVENTIONAL THYMOQUINONE 50 MG CAPSULE DISTRIBUTED BY TRIQUETRA HEALTH AND CONVENTIONAL BERBERINE 500 MG CAPSULE DISTRIBUTED BY MEDFUTURE IN HEALTHY ADULT HUMAN SUBJECTS UNDER FASTING CONDITIONS - Nil | CTRI/2024/10/074604 |
| Wound Healing After Endoscopic Sinus Surgery | Effect of Thymoquinone and Olive Oil on Wound Healing After Endoscopic Sinus Surgery in Patients With Nasal Polyposis | NCT06070311 |
